Division of General Internal Medicine and Public Health Archive — Page 7 of 7

microscope
February 13, 2014

Major grant creates clinical research network

Vanderbilt University Medical Center has received an 18-month, $6.9 million award to set up a Clinical Data Research Network (CDRN) that can reach millions of patients and speed the translation of research findings into clinical practice.

December 12, 2013

Brady, Rothman set for AACH leadership roles

Donald Brady, M.D., senior associate dean for Graduate Medical Education and Continuing Professional Development, will serve a one-year term as chair of the board of directors of the American Academy on Communication in Healthcare (AACH) for 2014. Brady spent this year serving as president and will transition into a one-year role as chair.

December 5, 2013

Day of events highlights efforts to fight diabetes

Vanderbilt University’s contributions to the field of diabetes — past and present — were celebrated recently during the annual Diabetes Day at the Vanderbilt Student Life Center.

February 21, 2013

VU experts help craft AMA paper on safe transitions for patients

“There and Home Again, Safely: 5 Responsibilities of Ambulatory Practices in High Quality Care Transitions,” a new white paper from the American Medical Association (AMA), is the work of a 19-member expert panel that included two Vanderbilt faculty members — Sunil Kripalani, M.D., M.Sc., associate professor of Medicine, and Amanda Salanitro M.D., MS, MSPH, instructor in Medicine, both from the section of Hospital Medicine in the Department of Medicine’s Division of General Internal Medicine and Public Health.

January 10, 2013

Study reviews medication adherence interventions

According to a medical literature review published last month in the Annals of Internal Medicine, approximately 50 percent of medications for chronic disease are not taken as prescribed.

November 8, 2012

Commonly prescribed oral diabetes drug offers cardiac benefits

Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.